Mechanism of Action
Undenatured type II collagen works on a fundamentally different principle from hydrolyzed collagen. It does not serve as raw material. Its native form allows it to be recognized by the intestinal immune system, triggering a specific biological process.
The mechanism unfolds in three stages. The collagen reaches the small intestine with its three-dimensional structure intact. It comes into contact with Peyer's patches (clusters of immune cells embedded in the intestinal wall). These cells identify the collagen's recognition patterns and initiate a process called oral tolerance.
This natural process educates the immune system to recognize joint collagen as a normal body component. Regulatory immune cells then migrate to the joint areas, where they help modulate the local response. The result is a joint environment more favorable to cartilage maintenance.
This specificity explains the very low doses used. Hydrolyzed collagen requires 5 to 10 g per day to supply building amino acids. 40 mg of undenatured collagen is enough to send the immune signal.
Key Benefits
- Moderate
A 180-day double-blind randomized trial shows significant improvement in joint comfort scores with 40 mg/day of undenatured type II collagen, exceeding the results observed with the glucosamine-chondroitin combination.
- Moderate
In physically active adults, supplementation improves knee extension and reduces post-exercise joint discomfort in a 120-day randomized placebo-controlled trial.
- Moderate
A 90-day controlled trial confirms improved joint function and knee comfort with undenatured type II collagen compared to placebo and the glucosamine-chondroitin combination.
- Moderate
The oral tolerance mechanism promotes the production of regulatory immune cells at the intestinal level, contributing to joint comfort through modulation of the local immune response.
- Moderate
Clinical trials show that 40 mg/day of undenatured form is sufficient to support joint comfort, while hydrolyzed forms require doses 100 to 250 times higher.
- Moderate
A 90-day randomized trial in healthy volunteers shows improved knee joint comfort during daily activities (stair climbing, prolonged sitting).
Dosage & Forms
Two main families of type II collagen exist in the supplement market. Hydrolyzed collagen (or collagen peptides) is obtained through enzymatic or chemical degradation. It provides free amino acids and absorbable dipeptides but loses its native three-dimensional structure. Studied effective doses range from 5 to 10 g per day.
Undenatured collagen (often referred to as UC-II in the literature) retains its intact three-dimensional conformation. This structural integrity is the key point: it enables recognition by the intestinal immune system and activation of oral tolerance. The studied effective dose is 40 mg per day, more than 100 times less than hydrolyzed forms.
Singular selected the undenatured form at 40 mg per day. This choice is based on favorable results in head-to-head trials against glucosamine-chondroitin and on the biological rationale of an immune mechanism that does not require massive doses.
In the Singular Formula
Inclusion rationale
Type II collagen in undenatured native form. Type II collagen is the main structural component of hyaline cartilage, which covers joint surfaces and provides mechanical cushioning between bones. The undenatured form preserves the original three-dimensional structure of the protein, fundamentally distinguishing it from hydrolyzed forms. This distinction is essential because the mechanism of action of undenatured type II collagen does not rely on amino acid supply but on immune recognition. By retaining its intact antigenic epitopes, it interacts with the Peyer's patches of the small intestine through a process called oral tolerance. This natural immune mechanism modulates the immune system's response toward endogenous joint collagen, contributing to joint comfort. Effective doses are very low (40 mg/day), precisely because the effect relies on an immune signal rather than a massive protein supply. Randomized clinical trials have compared undenatured type II collagen to glucosamine with chondroitin, showing favorable results on joint comfort scores. In the formula, type II collagen works in complementarity with glucosamine (also present), which takes a different pathway by providing the direct precursors of cartilage glycosaminoglycans. Two complementary mechanisms for a single objective.
Selected form
Non-denatured type II collagen (NUVICOL II), extracted from chicken sternum cartilage, manufactured in the Netherlands. The non-denatured form preserves the native three-dimensional structure of collagen, which is essential: denatured (hydrolysed) type II collagen loses its conformation and specific epitopes. This natural cartilage matrix also contains chondroitin sulphate and hydroxyproline, structural components of hyaline cartilage. Type II collagen is the predominant protein in articular cartilage. Single chicken source. Quality: no excipient.
Formula dosage
0 to 50 mg.
Synergies in the formula
Safety & Precautions
Undenatured type II collagen shows a favorable tolerability profile at the studied dose (40 mg/day). Clinical trials lasting 90 to 180 days report no significant adverse effects compared to placebo.
The source is chicken cartilage. Individuals with a known allergy to poultry proteins should avoid this bioactive. No cross-reactivity with egg is established, but caution is advised in cases of multiple avian protein sensitivities.
Use is not recommended during pregnancy and breastfeeding due to the lack of specific data in these populations. No study has evaluated safety in children.
As a precaution, individuals taking immunosuppressants should consult a healthcare professional before use. Since the mechanism of action involves the immune system, a theoretical interaction cannot be ruled out.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Lugo JP et al. | 2016 | Randomised Controlled Trial | Nutrition Journal | View on PubMed |
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study A 180-day multicenter trial comparing 40 mg/day of undenatured type II collagen to the glucosamine-chondroitin combination and placebo. Undenatured collagen significantly improves WOMAC joint comfort scores. | ||||
| Lugo JP et al. | 2013 | Randomised Controlled Trial | Journal of the International Society of Sports Nutrition | View on PubMed |
Undenatured type II collagen (UC-II) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers A 120-day trial in healthy, physically active volunteers. Undenatured collagen supplementation improves knee extension and post-exercise joint comfort. | ||||
| Crowley DC et al. | 2009 | Randomised Controlled Trial | International Journal of Medical Sciences | View on PubMed |
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial A 90-day trial comparing undenatured type II collagen to the glucosamine-chondroitin combination. The undenatured collagen group shows more pronounced improvement in joint function. | ||||
| Trentham DE et al. | 1993 | Randomised Controlled Trial | Science | View on PubMed |
Effects of oral administration of type II collagen on rheumatoid arthritis Foundational study demonstrating the efficacy of oral type II collagen administration in modulating the joint immune response. First clinical validation of the oral tolerance mechanism. | ||||
| Bagchi D et al. | 2002 | Systematic Review | International Journal of Clinical Pharmacology Research | View on PubMed |
Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration Mechanistic exploration of undenatured type II collagen confirming the role of oral tolerance and the involvement of regulatory T cells in the joint effect. | ||||
| Kumar A et al. | 2023 | Systematic Review | American Journal of Translational Research | View on PubMed |
Efficacy of undenatured collagen in knee osteoarthritis: review of the literature with limited meta-analysis Systematic review with limited meta-analysis pooling clinical trials on undenatured collagen for knee joint discomfort. Confirms a significant improvement in functional scores compared to placebo. | ||||